Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2025
상품코드:1912160
리서치사:QYResearch
발행일:2026년 01월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 BMP 2(골형성 단백질 2) 시장은 2024년 6억 9,700만 달러로 평가되었으며, 2031년까지 11억 2,000만 달러에 이를 것으로 예측됩니다.
이에 따라 2025년부터 2031년까지의 예측 기간에서 CAGR 6.77%를 기록할 전망입니다.
북미의 BMP 2(골형성 단백질 2) 시장은 2024년 4억 7,676만 달러에서 2031년까지 7억 5,400만 달러에 이를 것으로 예측되며, 2025년에서 2031년의 예측 기간 동안 CAGR 6.09%로 성장할 것으로 전망됩니다.
아시아태평양의 BMP 2(골형성 단백질 2) 시장은 2024년 1억 4,047만 달러에서 2031년까지 2억 5,059만 달러에 이를 것으로 예측되며, 2025년에서 2031년의 예측 기간 동안 CAGR 10.26%로 성장할 것으로 전망됩니다.
세계의 BMP 2(골형성 단백질 2) 시장의 주요 기업에는 Medtronic, Jiuyuan Gene Engineering, Cellumed 등이 있습니다. 2024년 기준으로 세계 3대 벤더의 수익 점유율은 약 98.84%를 차지했습니다.
본 보고서는 세계의 BMP 2(골형성 단백질 2) 시장에 대해 정량적 및 정성적 분석을 겸비한 종합적인 제시를 실시하는 것을 목적으로 하고 있습니다. 이에 따라, 독자의 BMP 2에 관한 사업 및 성장 전략 책정, 시장 경쟁 구도의 평가, 현행 마켓플레이스에서의 자사의 위치 분석, 그리고 정보에 근거한 사업 판단을 뒷받침합니다.
BMP 2(골형성 단백질 2) 시장의 규모, 추정 및 예측치는 2024년을 기준연도로 하여 2020년부터 2031년까지의 기간 동안의 과거 데이터와 예측 데이터에 근거해 수익(백만 달러) 단위로 제공됩니다. 본 보고서에서는 세계의 BMP 2(골형성 단백질 2) 시장을 종합적으로 세분화하고 있습니다. 지역별 시장 규모, 제품 유형별, 용도별 및 주요 기업별 시장 규모에 대해서도 제시합니다.
시장에 대한 깊은 이해를 위해 본 보고서는 경쟁 구도, 주요 경쟁사 및 각 시장 순위에 대한 프로파일을 제공합니다. 또한 기술 동향과 신제품 개발에 대해서도 논의했습니다.
본 보고서는 BMP 2(골형성 단백질 2) 관련 기업, 신규 진출기업 및 업계 체인 관련 기업에 대해 시장 전체 및 각 하위 부문(기업별, 유형별, 용도별, 지역별)의 수익에 관한 정보를 제공하여 시장 진입을 뒷받침합니다.
시장 세분화
기업별
Medtronic
Jiuyuan Gene Engineering
Cellumed
유형별 부문
스폰지 담체
하이드록시아파타이트 담체
용도별 부문
척추고정술
외상수술
구강턱 안면수술
재건수술
지역별 부문
북미
미국
캐나다
멕시코
아시아태평양
중국
한국
동남아시아
인도
유럽
독일
프랑스
영국
이탈리아
러시아
기타 유럽
남미
브라질
중동 및 아프리카
중동
아프리카
CSM
영문 목차
영문목차
The global Bone Morphogenetic Protein (BMP) 2 market was valued at US$ 697 million in 2024 and is anticipated to reach US$ 1120 million by 2031, witnessing a CAGR of 6.77% during the forecast period 2025-2031.
North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 476.76 million in 2024 to reach $ 754 million by 2031, at a CAGR of 6.09% during the forecast period of 2025 through 2031.
Asia-Pacific market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 140.47 million in 2024 to reach $ 250.59 million by 2031, at a CAGR of 10.26% during the forecast period of 2025 through 2031.
The major global companies of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering, Cellumed, etc. In 2024, the world's top three vendors accounted for approximately 98.84% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Protein (BMP) 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Protein (BMP) 2.
The Bone Morphogenetic Protein (BMP) 2 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bone Morphogenetic Protein (BMP) 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone Morphogenetic Protein (BMP) 2 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Jiuyuan Gene Engineering
Cellumed
Segment by Type
Sponge Carrier
Hydroxyapatite Carrier
Segment by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive Surgery
Segment by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
South Korea
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
South America
Brazil
Middle East & Africa
Middle East
Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sponge Carrier
1.2.3 Hydroxyapatite Carrier
1.3 Market by Application
1.3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Spinal Fusion
1.3.3 Trauma Surgery
1.3.4 Oral Maxillofacial Surgery
1.3.5 Reconstructive Surgery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Perspective (2020-2031)
2.2 Global Bone Morphogenetic Protein (BMP) 2 Growth Trends by Region
2.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Region (2020-2025)
2.2.3 Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Region (2026-2031)
2.3 Bone Morphogenetic Protein (BMP) 2 Market Dynamics
2.3.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends
2.3.2 Bone Morphogenetic Protein (BMP) 2 Market Drivers
2.3.3 Bone Morphogenetic Protein (BMP) 2 Market Challenges
2.3.4 Bone Morphogenetic Protein (BMP) 2 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue
3.1.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue (2020-2025)
3.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2020-2025)
3.2 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Company Type by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bone Morphogenetic Protein (BMP) 2 Revenue
3.4 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio
3.4.1 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio (CR3 and HHI)
3.4.2 Global Top 3 Companies by Bone Morphogenetic Protein (BMP) 2 Revenue in 2024
3.5 Global Key Players of Bone Morphogenetic Protein (BMP) 2 Head office and Area Served
3.6 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Product and Application
3.7 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Type
4.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Type (2020-2025)
4.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Type (2026-2031)
5 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Application
5.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Application (2020-2025)
5.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
6.2 North America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
6.4 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
6.7 Mexico
7 Europe
7.1 Europe Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
7.2 Europe Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
7.4 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
8 Asia-Pacific
8.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
8.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2020-2025)
8.4 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2026-2031)
8.5 China
8.6 South Korea
8.7 Southeast Asia
8.8 India
9 South America
9.1 South America Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
9.2 South America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 South America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
9.4 South America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
10.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
10.4 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
10.5 Middle East
10.6 Africa
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Introduction
11.1.4 Medtronic Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Jiuyuan Gene Engineering
11.2.1 Jiuyuan Gene Engineering Company Details
11.2.2 Jiuyuan Gene Engineering Business Overview
11.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Introduction
11.2.4 Jiuyuan Gene Engineering Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025)
11.3 Cellumed
11.3.1 Cellumed Company Details
11.3.2 Cellumed Business Overview
11.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Introduction
11.3.4 Cellumed Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025)
